Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Washington for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Washington only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Washington (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kevin Sanders (NPI 1376554154)

Field	Value
Entity Type	Individual
Organization	Kevin Sanders
Address	2940 S Meridian Ste 100
City	Puyallup
State	WA
ZIP	98373
Taxonomy	Radiation Oncology Physician
NPI Enumerated	August 10, 2006

Payer Source	Total Paid
Medicare	$4.5M
Medicaid	$0

Key Findings

This provider’s Medicare activity is concentrated: total Medicare revenue is $4.5M and the precomputed top 3 Medicare codes account for 74.6% of that revenue, led by A9607 ($2.6M, 58.7%), followed by G6015 ($365.4K, 8.3%) and 78815 ($338.6K, 7.6%). Such a concentration indicates a small set of high-revenue services drive the practice’s Medicare billing profile.

The code mix signals a radiation oncology practice oriented around high-cost radiopharmaceutical therapy and advanced external-beam services: A9607 is the dominant therapeutic radiopharmaceutical, G6015 and 77301 reflect intensive IMRT delivery, and 78815 indicates integrated PET/CT imaging support. Together these codes are consistent with an operation that provides both theranostic (radiopharmaceutical) treatments and sophisticated radiation planning/delivery capabilities.

Despite producing the largest share of Medicare dollars, A9607 is described as “typical, unremarkable volume” at the national level; the provider’s A9607 billing ($2.6M, 58.7%) ranks #9 of 44 providers nationally (81th percentile), placing them among the higher users of this therapeutic agent but still within the normal national distribution for the code. This suggests the provider’s heavy revenue reliance on A9607 is substantive locally but not an extreme national outlier.

The practice shows above-average national standing on IMRT-related planning and device codes: 77301 ($221.6K) ranks #64 of 3815 providers nationally (98th percentile; notably above typical national volume) and 77338 ($55.7K) ranks #106 of 3807 (97th percentile; notably above typical national volume). These high percentiles indicate a strong national-level presence in IMRT planning and MLC/device work, positioning the provider as a significant contributor in advanced external-beam services.

Advanced imaging and diagnostic radiopharmaceuticals contribute meaningful but smaller shares: 78815 accounts for $338.6K (7.6% of Medicare revenue) and ranks #638 of 6566 (90th percentile; typical, unremarkable volume), while A9596 and A9595 also appear as mid-level diagnostic agents by revenue. This mix implies the practice operates internal imaging and diagnostic workflows that complement its therapeutic offerings without dominating revenue.

This provider is effectively single-payer in the dataset: there is no Medicaid billing on file, so Medicare ($4.5M) represents the entire reported public-payer footprint. That concentration makes the practice operationally and contractually more exposed to Medicare policy, reimbursement changes, or utilization shifts affecting the small set of revenue-driving codes.

Several codes are flagged as notable statistical outliers at the national level: 77301 and 77338 are labeled “notably above typical national volume,” and 79101 is also “notably above typical national volume,” indicating unusually high engagement in certain specialized services relative to peers. At the same time, many high-revenue items (including A9607 and 78815) are described as “typical, unremarkable volume,” so the provider combines some nationally elevated IMRT activity with otherwise typical utilization of high-cost agents.

The provider’s NPI was enumerated 2006-08-10 (~20 years ago), indicating long tenure in the Medicare program; paired with the technical intensity reflected in billing (advanced IMRT, radiopharmaceutical therapy, PET/CT), this suggests an established radiation-oncology operation with sustained clinical and billing activity in specialized oncology services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

34 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
A9607	Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie	13,400	$190	$2.6M
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	1,250	$290	$365.4K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	290	$1,180	$338.6K
77301	Intensity modulated radiotherapy (IMRT) uses advanced computer technology to deliver very precise radiation beams that target and destroy the cancerous cells while avoiding the surrounding healthy…	150	$1,490	$221.6K
77014	N/A	1,400	$100	$136.8K
A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	160	$840	$134.4K
A9595	Piflufolastat f-18, diagnostic, 1 millicurie	250	$490	$123.2K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	260	$280	$71.2K
77338	In this procedure, the provider participates in the design and construction of one or more multi–leaf collimator, MLC, devices for intensity modulated radiation therapy, IMRT. IMRT is a radiotherapy…	150	$370	$55.7K
78816	The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The…	50	$1,170	$53.7K

Showing 1–10 of 34

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 34 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Washington Distribution

Kevin Sanders — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Washington

Full comparison — all codes billed, vs. state median

34 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
A9607	1	10	7,000	$190	$1.7M
G6015	2	30	650	$290	$204.1K
A9596	6	10	180	$830	$183K
A9595	6	10	200	$480	$150.1K
78815	14	110	50	$430	$50.3K
77373	6	20	40	$810	$40.3K
A9587	1	10	760	$50	$34.9K
77014	5	120	450	$60	$32.7K
77301	1	90	30	$770	$28.5K
77427	25	110	150	$150	$26.5K

Showing 1–10 of 34

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kevin Sanders, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kenneth Bergman	WA	Radiation Oncology Physician	$2.2M	$0

Nearby Providers

Other providers in the same ZIP code as Kevin Sanders, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kids Choice Dental Puyallup, LLC	WA	Pediatric Dentistry	$0	$8.7M
Total Renal Care Inc	WA	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$4.4M
Sea Mar Community Health Centers	WA	Federally Qualified Health Center (FQHC)	$0	$3.3M
Andrea Veatch	WA	Hematology & Oncology Physician	$1.7M	$0
Aaron Rasmussen	WA	Medical Physician Assistant	$449.8K	$19.4K
Mohammed Kanaan	WA	Hematology & Oncology Physician	$457.3K	$0
Jeffrey Newman	WA	Procedural Dermatology Physician	$320.2K	$0
Marina Dolmatova	WA	Family Nurse Practitioner	$268.5K	$0
Sibel Blau	WA	Hematology & Oncology Physician	$258K	$0
Jason Meeker	WA	Dermatology Physician	$216.1K	$0

Kevin Sanders — Billing Profile & Reimbursement Data

Sign up for Kevin Sanders — Billing Profile & Reimbursement Data policy alerts

Kevin Sanders — Billing Profile & Reimbursement Data

Sign up for Kevin Sanders — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References